trial

Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

NCTId NCT04898270
as of 2026-07-01
at a glance
Phase 4 · Completed
Enrollment 30 (actual)
Primary completion 2020-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
30 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
Single
Start
2019-12-19
Primary completion
2020-12-31
Eligibility
ALL · 20 Years · 65 Years

Interventions & indications

Sponsors

Investigators

1
Chia-Jui Tsai, M.D.Principal Investigator

Sites

1 total
Taichung, Taiwan

Facts & assertions

4 sourced
Enrollment
30
Phase
PHASE4
Primary Completion Date
2020-12-31
Status
COMPLETED
relationships
The graph out of here